Goldline Pharmaceutical Limited, a active public limited company, was established on 02 August 2004 in Nagpur, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U51397MH2004PLC147806. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹13.50 Cr and a paid-up capital of ₹8.71 Cr.
Formerly known as Goldline Pharmaceutical Private Limited. It upholds a compliant status. Employing 85 professional, Its leadership includes Swapan Khandelwal (Whole-Time Director), Amol Laxmikant Mujumdar (Managing Director), Mehul Hari Ranade (Director). Past directors included Girish Damodar Kalamkar, Swapan Khandelwal, Amol Laxmikant Mujumdar. It holds ₹8.54 Cr open charges and ₹3.53 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 103,F-1Leelaapartmentshilpahsgsociety,Nearsaptagirinagar,Shanidham,Narend, Ra Nagar,, Nagpur, Maharashtra, 440015.
U51397MH2004PLC147806
147806
02 August 2004
₹13.50 Cr
₹8.71 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Goldline Pharmaceutical Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swapan Khandelwal | Whole-Time Director | 11 Apr 2011 | Current |
| Amol Laxmikant Mujumdar | Managing Director | 02 Aug 2004 | Current |
| Mehul Hari Ranade | Director | 30 Sep 2024 | Current |
| Prashant Shrikrishna Karkare | Director | 16 Jul 2013 | Current |
| Renuka Saurabh Borole | Director | 30 Sep 2024 | Current |
| Shraddha Kiran Kulkarni | Additional Director | 17 Oct 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 12 Apr 2011 | Past |
| Pramod Abcsdd | Director | 10 Nov 2021 | Past |
| Pramod Abcsdd | Director | 01 Apr 2009 | Past |
| Pramod Abcsdd | Director | 09 Mar 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Goldline Pharmaceutical Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2023, Goldline Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹85,350,000.00
₹35,300,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Dec 2024 | Others | ₹4.21 M | Open |
| 02 May 2022 | Bank Of India | ₹4.60 M | Open |
| 16 Jan 2013 | Bank Of India | ₹7.65 Cr | Open |
| 27 Dec 2013 | Bank Of India | ₹0.80 M | Satisfied |
| 17 Feb 2011 | State Bank Of India | ₹3.45 Cr | Satisfied |
Explore comprehensive loan charge details -
Goldline Pharmaceutical has a workforce of 85 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Goldline Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Goldline Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Dipti Sharad Bhusari was appointed as a Cfo was appointed as a Cfo on 17 Jan 2025 & has been associated with this company since 10 months 15 days . was documented.
A charge with Others amounted to Rs. 0.42 Cr with Charge ID 101015954 was registered on 12 Dec 2024. was recorded as a recent event.
The activity A charge registered on 27 Dec 2013 via Charge ID 100814496 with Bank Of India was fully satisfied on 05 Dec 2024. was completed.
Progress on Ruchi Sanket Modi was appointed as a Company Secretary was appointed as a Company Secretary on 05 Nov 2024 & has been associated with this company since 1 year 27 days . was documented.
Progress on Shraddha Kiran Kulkarni was appointed as a Additional Director was appointed as a Additional Director on 17 Oct 2024 & has been associated with this company since 1 year 1 month . was documented.
Progress on Goldline Pharmaceutical Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The CIN of Goldline Pharmaceutical Limited is U51397MH2004PLC147806.
Goldline Pharmaceutical Limited is headquartered at 103,F-1Leelaapartmentshilpahsgsociety,Nearsaptagirinagar,Shanidham,Narend, Ra Nagar,, Nagpur, Maharashtra, 440015.
Goldline Pharmaceutical Limited was incorporated on 02 August 2004.
The current directors of Goldline Pharmaceutical Limited are
The primary industry of Goldline Pharmaceutical Limited is Manufacturing.
Goldline Pharmaceutical Limited is unlisted.
The authorized capital of Goldline Pharmaceutical Limited is ₹13.50 Cr, and the paid-up capital is ₹8.71 Cr.
The compliance status of Goldline Pharmaceutical Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX